ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AVCT Avacta Group Plc

45.25
0.15 (0.33%)
Last Updated: 13:49:58
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Avacta Group Plc LSE:AVCT London Ordinary Share GB00BYYW9G87 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.15 0.33% 45.25 44.50 46.00 45.50 44.55 44.75 1,041,676 13:49:58
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 10.06M -39.19M -0.1382 -3.27 128.34M
Avacta Group Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AVCT. The last closing price for Avacta was 45.10p. Over the last year, Avacta shares have traded in a share price range of 43.25p to 166.50p.

Avacta currently has 283,614,110 shares in issue. The market capitalisation of Avacta is £128.34 million. Avacta has a price to earnings ratio (PE ratio) of -3.27.

Avacta Share Discussion Threads

Showing 4176 to 4197 of 79850 messages
Chat Pages: Latest  170  169  168  167  166  165  164  163  162  161  160  159  Older
DateSubjectAuthorDiscuss
05/4/2019
09:10
In one of the recent presentations, I believe it was the Sharesoc one. He made reference to the LG deal upfront payments in the Q&A. He said it was "single digit millions". So between 1m and 9m then.
milkmonsta
05/4/2019
08:13
Tuesday we should get visibility of the scale of upfront and milestone payments ... the notes in the accounts ought to point to the period over which they will be recognised.
the drewster
03/4/2019
09:57
So far it is the usual story wonderfull prospects but sales never materialize.
poacher45
02/4/2019
17:10
Well,if there is more news coming soon.
Let's hope it is not as vague as the previous announcements!.

lantanatony
02/4/2019
13:28
The whole sector is now on a daily basis announcing M&A transactions, valuations going north.The stock is at ridiculous low levels on a sector read across .More news shortly I am sure
zebrano10
01/4/2019
15:14
Spectator bioscience pick.
the drewster
28/3/2019
12:39
The presentation from Avacta delivered at the London Seminar on 13th March is available in our members area here:
sharesoc
28/3/2019
12:29
We have action.
1i1i1i
27/3/2019
10:01
Too true , and i invested a measured amount accordingly on account of AIMs reputation.
escapetohome
27/3/2019
09:54
or the first draft of the results RNS is leaking? This is AIM after all.
the drewster
27/3/2019
09:49
Im annoyed this is falling, but im not yielding at this price.

I see this as an attempt to pick up shares in advance of news.

escapetohome
26/3/2019
08:31
So much to look forward to this year - The licensing deal with New England Biolabs is a perfect example of the type of deals we have in the pipeline of Affimer reagent evaluations and I expect that we will see more of these deals emerge in 2019 with both large and small partners across multiple markets.
1i1i1i
20/3/2019
16:31
Well, had a limit order in all day, only managed 25 thóugh.
bumpa33
20/3/2019
12:57
... had a leading role at the Oncology department at Roche ..
hampton58
20/3/2019
10:23
remains quiet here, had a quick word with the mm’s, can buy 50k off Cantors, sell 50k with KBC. Cantors is just book stock, but KBC have a buyer in the background. The other mm’s have no position to speak of.
bumpa33
19/3/2019
16:34
Added more today..
losses
19/3/2019
15:15
Think our man came across well, looked like the audience were happy with the answers to the Q&A. Share price looking a bit on the cheap side following its retraction.
1i1i1i
19/3/2019
15:04
Thanks for the video link to the Sharesoc presentation last week


Note to self: In future do not sit in the front row wearing spotted socks if you are going to ask questions at a ShareSoc growth company seminar 😲

timbo003
15/3/2019
12:41
ThxYes it be a very exciting Q2/Q3 with plenty of news flow which will drive the price north.Barclays and Cowen life science conferences had some very bullish presentations by the majors and their plans for the sector.You should applied some read across valuation and you will get some very different share price.
hampton58
15/3/2019
08:28
Avacta presentation at ShareSoc London 13.3.19
by Dr Alastair Smith



Dr Smith gives a comprehensive overview of AVCT, followed by the Q&A.

tomps2
14/3/2019
12:34
Down? Come on mr market.

You cannot be serious.

Get real.

Up Up Up is the way to go. As you shall see.

escapetohome
13/3/2019
18:37
Jonnybgood4 - How many boards are you going to put this rather silly statement on!
killieboy
Chat Pages: Latest  170  169  168  167  166  165  164  163  162  161  160  159  Older

Your Recent History

Delayed Upgrade Clock